RECRUITING

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Official Title

Northwestern Ovarian Cancer Early Detection & Prevention Program: A Specimen and Data Study

Quick Facts

Study Start:2000-03
Study Completion:2040-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00005095

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Kisha Hope
CONTACT
312-503-3857
kisha.hope@northwestern.edu
Anne Grace
CONTACT
312-503-4165

Principal Investigator

Lee P. Shulman, MD
STUDY_CHAIR
Robert H. Lurie Cancer Center

Study Locations (Sites)

Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, 60611-3013
United States

Collaborators and Investigators

Sponsor: Northwestern University

  • Lee P. Shulman, MD, STUDY_CHAIR, Robert H. Lurie Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2000-03
Study Completion Date2040-12

Study Record Updates

Study Start Date2000-03
Study Completion Date2040-12

Terms related to this study

Keywords Provided by Researchers

  • ovarian epithelial cancer
  • hereditary breast/ovarian cancer (BRCA1, BRCA2)
  • fallopian tube cancer
  • ovarian germ cell tumor
  • ovarian sarcoma
  • ovarian stromal cancer
  • endometrial cancer
  • uterine sarcoma
  • vaginal cancer
  • cervical cancer
  • vulvar cancer
  • uterine leiomyomata

Additional Relevant MeSH Terms

  • Cervical Cancer
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Hereditary Breast/Ovarian Cancer (brca1, brca2)
  • Ovarian Cancer
  • Sarcoma
  • Uterine Leiomyomata
  • Vaginal Cancer
  • Vulvar Cancer